Lisa Walter
Stock Analyst at RBC Capital
(2.76)
# 2,016
Out of 5,005 analysts
4
Total ratings
66.67%
Success rate
25.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Initiates: Outperform | $569 | $453.07 | +25.59% | 1 | Sep 26, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Outperform | $45 → $41 | $21.65 | +89.38% | 1 | Aug 7, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Sector Perform | $17 → $19 | $23.80 | -20.17% | 1 | Aug 1, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Outperform | $28 | $13.73 | +103.93% | 1 | Jun 17, 2025 |
United Therapeutics
Sep 26, 2025
Initiates: Outperform
Price Target: $569
Current: $453.07
Upside: +25.59%
Viridian Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $41
Current: $21.65
Upside: +89.38%
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Sector Perform
Price Target: $17 → $19
Current: $23.80
Upside: -20.17%
EyePoint Pharmaceuticals
Jun 17, 2025
Initiates: Outperform
Price Target: $28
Current: $13.73
Upside: +103.93%